Compare ANAB & KARO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANAB | KARO |
|---|---|---|
| Founded | 2005 | 2001 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2015 | 2020 |
| Metric | ANAB | KARO |
|---|---|---|
| Price | $53.61 | $63.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 6 |
| Target Price | ★ $71.67 | $59.33 |
| AVG Volume (30 Days) | ★ 818.3K | 133.9K |
| Earning Date | 05-08-2026 | 05-15-2026 |
| Dividend Yield | N/A | ★ 2.52% |
| EPS Growth | ★ 91.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $234,603,000.00 | N/A |
| Revenue This Year | N/A | $22.17 |
| Revenue Next Year | $52.14 | $16.74 |
| P/E Ratio | ★ N/A | $24.13 |
| Revenue Growth | ★ 157.01 | N/A |
| 52 Week Low | $17.11 | $41.25 |
| 52 Week High | $73.30 | $66.19 |
| Indicator | ANAB | KARO |
|---|---|---|
| Relative Strength Index (RSI) | 44.82 | 68.05 |
| Support Level | $52.32 | $43.38 |
| Resistance Level | $57.70 | $66.19 |
| Average True Range (ATR) | 4.55 | 2.87 |
| MACD | -0.98 | 0.17 |
| Stochastic Oscillator | 24.72 | 75.36 |
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
Karooooo Ltd is a provider of an operational intelligence platform. Through its cloud platform, the company enables fleet and asset management, fuel management, workforce management, logistics, safety, including AI-assisted video safety, compliance, risk, and environmental impact management. Its segments are: Cartrack, which generates the majority of revenue, provides an operational intelligence platform that maximizes the value of transportation, operations, and workflow data through insightful real-time data analytics to connected vehicles and equipment, and Karooooo Logistics provides a software application enabling the management of last-mile B2B delivery and general operational logistics (Delivery-as-a-Service or DaaS). It generates the majority of its revenue from South Africa.